Literature DB >> 9252514

Signal transduction pathways via guanylin and uroguanylin in stomach and intestine.

R M London1, W J Krause, X Fan, S L Eber, L R Forte.   

Abstract

Guanylin and uroguanylin are peptides that activate receptor guanylate cyclases (GCs) and elicit increased intestinal secretion. Bacteria that cause traveler's diarrhea produce heat-stable toxins (STs) that mimic this action. Investigation of the distribution and identity of receptor GCs in the gastrointestinal tract of rats revealed that receptors were localized to epithelial cells in stomach and intestine. Clusters of cells in gastric mucosa and enterocytes lining the intestine exhibited specific binding of 125I-labeled ST. Ligated loops of stomach and intestine treated with intraluminal ST had significant increases in guanosine 3',5'-cyclic monophosphate (cGMP), with duodenum exhibiting the greatest response. Expression of guanylate cyclase C (GCC) mRNA and a truncated, GCC-like mRNA was found in both stomach and intestine. Both mRNAs were isolated as cDNAs encoding the GC catalytic domain. The 0.9-kilobase (kb) cDNA is 99.8% identical to GCC, whereas the truncated, 0.75-kb GCC-like cDNA has a 159-nucleotide deletion and is 96.6% identical to GCC at the protein level. Uroguanylin and guanylin mRNAs were detected in stomach and intestine. Uroguanylin mRNA was most abundant in small intestine, whereas guanylin mRNA was highest in large intestine. Thus the stomach and intestine are targets for regulation of transport by guanylin and uroguanylin via cGMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252514     DOI: 10.1152/ajpgi.1997.273.1.G93

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity.

Authors:  Maria Grazia Rambotti; Antonio Spreca; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Expression of guanylin in "pars tuberalis-specific cells" and gonadotrophs of rat adenohypophysis.

Authors:  L D'Este; H Kulaksiz; U Rausch; R Vaccaro; T Wenger; Y Tokunaga; T G Renda; Y Cetin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Guanylin and functional coupling proteins in the hepatobiliary system of rat and guinea pig.

Authors:  Karen Schwabe; Yalcin Cetin
Journal:  Histochem Cell Biol       Date:  2012-02-07       Impact factor: 4.304

4.  Guanylin-immunoreactive cells in the female and male rat adenohypophysis and their changes under various physiological and experimental conditions.

Authors:  Loredana D'Este; Arianna Casini; Yalcin Cetin; Tibor Wenger; Tindaro G Renda
Journal:  Histochem Cell Biol       Date:  2005-04-06       Impact factor: 4.304

5.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.

Authors:  C Folgueira; E Sanchez-Rebordelo; S Barja-Fernandez; R Leis; S Tovar; F F Casanueva; C Dieguez; R Nogueiras; L M Seoane
Journal:  Eur J Nutr       Date:  2015-03-06       Impact factor: 5.614

6.  Interaction of the epithelial Ca2+ channels TRPV5 and TRPV6 with the intestine- and kidney-enriched PDZ protein NHERF4.

Authors:  Stan F J van de Graaf; Joost G J Hoenderop; Annemiete W C M van der Kemp; Serge M Gisler; René J M Bindels
Journal:  Pflugers Arch       Date:  2006-03-25       Impact factor: 3.657

Review 7.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

8.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

9.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

10.  Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.

Authors:  Kunwar Shailubhai; Vaseem Palejwala; Krishna Priya Arjunan; Sayali Saykhedkar; Bradley Nefsky; John A Foss; Stephen Comiskey; Gary S Jacob; Scott E Plevy
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.